Acanthosis nigricans is commonly associated with which condition?

Prepare effectively for the PPC/OMM Block 6 Exam with comprehensive question sets, detailed explanations, and insightful tips. Ace your test confidently!

Multiple Choice

Acanthosis nigricans is commonly associated with which condition?

Explanation:
Acanthosis nigricans signals insulin resistance. The dark, velvety patches that appear in areas like the neck, axillae, and groin come from the skin’s response to high insulin levels. When the body’s cells don’t respond well to insulin, the pancreas makes more of it (hyperinsulinemia), and this excess insulin can stimulate growth factor receptors in skin cells, causing the thickened, pigmented plaques. That link to insulin resistance places acanthosis nigricans with conditions such as obesity, metabolic syndrome, polycystic ovary syndrome, and type 2 diabetes risk. It isn’t typically a sign of autoimmune disease, liver failure, or a normal aging variant. Autoimmune conditions and liver failure have other characteristic signs and skin changes, and aging skin doesn’t usually present with this specific velvety hyperpigmentation in flexural areas.

Acanthosis nigricans signals insulin resistance. The dark, velvety patches that appear in areas like the neck, axillae, and groin come from the skin’s response to high insulin levels. When the body’s cells don’t respond well to insulin, the pancreas makes more of it (hyperinsulinemia), and this excess insulin can stimulate growth factor receptors in skin cells, causing the thickened, pigmented plaques. That link to insulin resistance places acanthosis nigricans with conditions such as obesity, metabolic syndrome, polycystic ovary syndrome, and type 2 diabetes risk.

It isn’t typically a sign of autoimmune disease, liver failure, or a normal aging variant. Autoimmune conditions and liver failure have other characteristic signs and skin changes, and aging skin doesn’t usually present with this specific velvety hyperpigmentation in flexural areas.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy